The News Feed

Presbyopia

Phentolamine Phase III Data Shows Success in Quickly Reversing Dilation

Roughly half of test subjects—48.9% in one study and 58% in another—saw a return to baseline pupil size within 90 minutes. Hyperemia and discomfort each occurred in about 11% of patients.

September 20, 2024

New Daily Multifocal Lens Accommodates More Presbyopes

The “Clariti 1-day Multifocal 3 Add” uses different optical designs for low, medium and high plus powers and offers a wider sphere range than its predecessor.

July 16, 2024

Reading Speed, Gaze Behavior Differs Between Types of Presbyopia Correction

Researchers observed variance in head movements between wearers of single-vision contact lenses, multifocal CLs and progressive addition lenses.

April 10, 2024

Pilocarpine 1.25% Impacts Night Driving

Study shows clinicians should take this into consideration when prescribing the medication to presbyopes.

December 8, 2023

FDA Approves Second Presbyopia Drop

A new low-dose pilocarpine agent can be administered up to twice a day for maximum duration of effect. It is hoped to result in fewer adverse effects than Vuity.

October 18, 2023

Alcon Adds Multifocal Option to Total30 Line

The company says the new lens is designed to maintain hydration and comfort throughout a month of wear.

October 10, 2023

Experts Attempt to Find Consensus on Presbyopic IOL Use

A panel agreed on many aspects of pre-op and intraoperative decision-making. They disagreed, however, when considering issues related to lens selection.

May 31, 2023